Roche's Xofluza Reduces Flu Symptoms In Children

The Swiss group's one-dose drug, seen as a future growth driver, is as effective as its off-patent blockbuster Tamiflu in treating children. 

Sick_Girl
One in three children develop flu every year • Source: Shutterstock

Roche's plans to expand the label on Xofluza have been boosted by late-stage data showing that the one-dose influenza medicine has proved to be a safe and effective treatment in otherwise healthy children.

The Swiss major revealed that the Phase III MINISTONE-2 study met its primary endpoint, demonstrating that Xofluza (baloxavir marboxil), given...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anti-infective

More from Therapeutic Category